EGFR and colorectal cancer: Indeed, in colorectal cancer it has been demonstrated that a sub-clone resistant to the EGFR blockade expresses TGF-α, which, by sustaining EGFR/ERK pathways, protects their sensitive counterparts from EGFR inhibitors [178].